# EDGAR Filing Document

**Accession Number:** 0001712922
**File Stem:** 0001104659-23-021720
**Filing Date:** 2023-2
**Character Count:** 33009
**Document Hash:** caeaef6e3f07bc983253f959659e6cf1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-021720.hdr.sgml**: 20230214

**ACCESSION NUMBER**: 0001104659-23-021720

**CONFORMED SUBMISSION TYPE**: SC 13G/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230214

**DATE AS OF CHANGE**: 20230214

**GROUP MEMBERS**: DALIA BLEYER

**GROUP MEMBERS**: NEXTECH V GP S.A R.L.

**GROUP MEMBERS**: THOMAS LIPS

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Kinnate Biopharma Inc.
- **CENTRAL INDEX KEY:** 0001797768
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 824566526
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-91893
- **FILM NUMBER:** 23630258

**BUSINESS ADDRESS:**
- **STREET 1:** 11975 EL CAMINO REAL, STE 101
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92130
- **BUSINESS PHONE:** 8582994699

**MAIL ADDRESS:**
- **STREET 1:** 11975 EL CAMINO REAL, STE 101
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92130
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Nextech V Oncology S.C.S., SICAV-SIF
- **CENTRAL INDEX KEY:** 0001712922
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** N4
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A

**BUSINESS ADDRESS:**
- **STREET 1:** 7, RUE LOU HEMMER
- **CITY:** LUXEMBOURG-FINDEL
- **STATE:** N4
- **ZIP:** L-1748
- **BUSINESS PHONE:** 352-246-160-6000

**MAIL ADDRESS:**
- **STREET 1:** 7, RUE LOU HEMMER
- **CITY:** LUXEMBOURG-FINDEL
- **STATE:** N4
- **ZIP:** L-1748

---

| |
|:---|
| **UNITED STATES** |
| **SECURITIES AND EXCHANGE COMMISSION** |
| **Washington, D.C. 20549** |

---

**SCHEDULE 13G**

**Under the Securities Exchange Act of 1934<br> (Amendment No. 1)\***

**Kinnate Biopharma Inc.**

(Name of Issuer)

**Common Stock $0.0001 par value**

(Title of Class of Securities)

**49705R 10 5**

(CUSIP Number)

**December 31, 2022** 

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

---

| | |
|:---|:---|
| ¨ | Rule 13d-1(b) |
| ¨ | Rule 13d-1(c) |
| x | Rule 13d-1(d) |

---

\*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| CUSIP No. 49705R 10 5 | CUSIP No. 49705R 10 5 | CUSIP No. 49705R 10 5 | CUSIP No. 49705R 10 5 | CUSIP No. 49705R 10 5 | CUSIP No. 49705R 10 5 |
|  | 1. | Names of Reporting Persons<br> Nextech V Oncology S.C.S., SICAV-SIF | Names of Reporting Persons<br> Nextech V Oncology S.C.S., SICAV-SIF | Names of Reporting Persons<br> Nextech V Oncology S.C.S., SICAV-SIF | Names of Reporting Persons<br> Nextech V Oncology S.C.S., SICAV-SIF |
|  | 2. | Check the Appropriate Box if a Member of a Group (See Instructions) | Check the Appropriate Box if a Member of a Group (See Instructions) | Check the Appropriate Box if a Member of a Group (See Instructions) | Check the Appropriate Box if a Member of a Group (See Instructions) |
|  |  | (a) | (a) | ¨ | ¨ |
|  |  | (b) | (b) | ⌧ (1) | ⌧ (1) |
|  | 3. | SEC Use Only | SEC Use Only | SEC Use Only | SEC Use Only |
|  | 4. | Citizenship or Place of Organization <br> Luxembourg | Citizenship or Place of Organization <br> Luxembourg | Citizenship or Place of Organization <br> Luxembourg | Citizenship or Place of Organization <br> Luxembourg |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 5. | 5. | Sole Voting Power <br> 2,329,480 shares |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 6. | 6. | Shared Voting Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 7. | 7. | Sole Dispositive Power <br> 2,329,480 shares |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 8. | 8. | Shared Dispositive Power <br> 0 |
|  | 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br> 2,329,480 shares | Aggregate Amount Beneficially Owned by Each Reporting Person<br> 2,329,480 shares | Aggregate Amount Beneficially Owned by Each Reporting Person<br> 2,329,480 shares | Aggregate Amount Beneficially Owned by Each Reporting Person<br> 2,329,480 shares |
|  | 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) □ | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) □ | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) □ | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) □ |
|  | 11. | Percent of Class Represented by Amount in Row (9)<br> 5.3% (2) | Percent of Class Represented by Amount in Row (9)<br> 5.3% (2) | Percent of Class Represented by Amount in Row (9)<br> 5.3% (2) | Percent of Class Represented by Amount in Row (9)<br> 5.3% (2) |
|  | 12. | Type of Reporting Person (See Instructions)<br> PN | Type of Reporting Person (See Instructions)<br> PN | Type of Reporting Person (See Instructions)<br> PN | Type of Reporting Person (See Instructions)<br> PN |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) This Schedule 13G is filed by Nextech V Oncology S.C.S., SICAV-SIF ("Nextech V LP"), Nextech V GP S.à. r.l.
 ("Nextech V GP"), Thomas Lips ("Lips"), Dalia Bleyer ("Bleyer") and Ian Charoub
 ("Charoub" and together with Nextech V LP, Nextech V GP, Lips and Bleyer, collectively, the "Reporting
 Persons"). The Reporting Persons expressly disclaim status as a "group" for purposes of this Schedule 13G.

&nbsp;&nbsp;&nbsp;&nbsp;(2) The percent of class was calculated based on 44,164,683 shares of Common Stock outstanding as of November 7, 2022, as reported in
the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 10, 2022.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| CUSIP No. 49705R 10 5 | CUSIP No. 49705R 10 5 | CUSIP No. 49705R 10 5 | CUSIP No. 49705R 10 5 | CUSIP No. 49705R 10 5 | CUSIP No. 49705R 10 5 |
|  | 1. | Names of Reporting Persons<br> Nextech V GP S.à r.l. | Names of Reporting Persons<br> Nextech V GP S.à r.l. | Names of Reporting Persons<br> Nextech V GP S.à r.l. | Names of Reporting Persons<br> Nextech V GP S.à r.l. |
|  | 2. | Check the Appropriate Box if a Member of a Group (See Instructions) | Check the Appropriate Box if a Member of a Group (See Instructions) | Check the Appropriate Box if a Member of a Group (See Instructions) | Check the Appropriate Box if a Member of a Group (See Instructions) |
|  |  | (a) | (a) | ¨ | ¨ |
|  |  | (b) | (b) | ⌧ (1) | ⌧ (1) |
|  | 3. | SEC Use Only | SEC Use Only | SEC Use Only | SEC Use Only |
|  | 4. | Citizenship or Place of Organization <br> Luxembourg | Citizenship or Place of Organization <br> Luxembourg | Citizenship or Place of Organization <br> Luxembourg | Citizenship or Place of Organization <br> Luxembourg |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 5. | 5. | Sole Voting Power <br> 2,329,480 shares |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 6. | 6. | Shared Voting Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 7. | 7. | Sole Dispositive Power <br> 2,329,480 shares |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 8. | 8. | Shared Dispositive Power <br> 0 |
|  | 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br> 2,329,480 shares | Aggregate Amount Beneficially Owned by Each Reporting Person<br> 2,329,480 shares | Aggregate Amount Beneficially Owned by Each Reporting Person<br> 2,329,480 shares | Aggregate Amount Beneficially Owned by Each Reporting Person<br> 2,329,480 shares |
|  | 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) □ | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) □ | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) □ | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) □ |
|  | 11. | Percent of Class Represented by Amount in Row (9)<br> 5.3% (2) | Percent of Class Represented by Amount in Row (9)<br> 5.3% (2) | Percent of Class Represented by Amount in Row (9)<br> 5.3% (2) | Percent of Class Represented by Amount in Row (9)<br> 5.3% (2) |
|  | 12. | Type of Reporting Person (See Instructions)<br> OO | Type of Reporting Person (See Instructions)<br> OO | Type of Reporting Person (See Instructions)<br> OO | Type of Reporting Person (See Instructions)<br> OO |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a "group" for
purposes of this Schedule 13G.

&nbsp;&nbsp;&nbsp;&nbsp;(2) The percent of class was calculated based on 44,164,683 shares of Common Stock outstanding as of November 7, 2022, as reported in
the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 10, 2022.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| CUSIP No. 49705R 10 5 | CUSIP No. 49705R 10 5 | CUSIP No. 49705R 10 5 | CUSIP No. 49705R 10 5 | CUSIP No. 49705R 10 5 | CUSIP No. 49705R 10 5 |
|  | 1. | Names of Reporting Persons<br> Thomas Lips | Names of Reporting Persons<br> Thomas Lips | Names of Reporting Persons<br> Thomas Lips | Names of Reporting Persons<br> Thomas Lips |
|  | 2. | Check the Appropriate Box if a Member of a Group (See Instructions) | Check the Appropriate Box if a Member of a Group (See Instructions) | Check the Appropriate Box if a Member of a Group (See Instructions) | Check the Appropriate Box if a Member of a Group (See Instructions) |
|  |  | (a) | (a) | ¨ | ¨ |
|  |  | (b) | (b) | ⌧ (1) | ⌧ (1) |
|  | 3. | SEC Use Only | SEC Use Only | SEC Use Only | SEC Use Only |
|  | 4. | Citizenship or Place of Organization <br> Switzerland | Citizenship or Place of Organization <br> Switzerland | Citizenship or Place of Organization <br> Switzerland | Citizenship or Place of Organization <br> Switzerland |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 5. | 5. | Sole Voting Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 6. | 6. | Shared Voting Power <br> 2,329,480 shares |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 7. | 7. | Sole Dispositive Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 8. | 8. | Shared Dispositive Power <br> 2,329,480 shares |
|  | 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br> 2,329,480 shares | Aggregate Amount Beneficially Owned by Each Reporting Person<br> 2,329,480 shares | Aggregate Amount Beneficially Owned by Each Reporting Person<br> 2,329,480 shares | Aggregate Amount Beneficially Owned by Each Reporting Person<br> 2,329,480 shares |
|  | 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) □ | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) □ | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) □ | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) □ |
|  | 11. | Percent of Class Represented by Amount in Row (9)<br> 5.3% (2) | Percent of Class Represented by Amount in Row (9)<br> 5.3% (2) | Percent of Class Represented by Amount in Row (9)<br> 5.3% (2) | Percent of Class Represented by Amount in Row (9)<br> 5.3% (2) |
|  | 12. | Type of Reporting Person (See Instructions)<br> IN | Type of Reporting Person (See Instructions)<br> IN | Type of Reporting Person (See Instructions)<br> IN | Type of Reporting Person (See Instructions)<br> IN |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a "group" for
purposes of this Schedule 13G.

&nbsp;&nbsp;&nbsp;&nbsp;(2) The percent of class was calculated based on 44,164,683 shares of Common Stock outstanding as of November 7, 2022, as reported in
the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 10, 2022.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| CUSIP No. 49705R 10 5 | CUSIP No. 49705R 10 5 | CUSIP No. 49705R 10 5 | CUSIP No. 49705R 10 5 | CUSIP No. 49705R 10 5 | CUSIP No. 49705R 10 5 |
|  | 1. | Names of Reporting Persons<br> Dalia Bleyer | Names of Reporting Persons<br> Dalia Bleyer | Names of Reporting Persons<br> Dalia Bleyer | Names of Reporting Persons<br> Dalia Bleyer |
|  | 2. | Check the Appropriate Box if a Member of a Group (See Instructions) | Check the Appropriate Box if a Member of a Group (See Instructions) | Check the Appropriate Box if a Member of a Group (See Instructions) | Check the Appropriate Box if a Member of a Group (See Instructions) |
|  |  | (a) | (a) | ¨ | ¨ |
|  |  | (b) | (b) | ⌧ (1) | ⌧ (1) |
|  | 3. | SEC Use Only | SEC Use Only | SEC Use Only | SEC Use Only |
|  | 4. | Citizenship or Place of Organization <br> Lithuania | Citizenship or Place of Organization <br> Lithuania | Citizenship or Place of Organization <br> Lithuania | Citizenship or Place of Organization <br> Lithuania |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 5. | 5. | Sole Voting Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 6. | 6. | Shared Voting Power <br> 2,329,480 shares |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 7. | 7. | Sole Dispositive Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 8. | 8. | Shared Dispositive Power <br> 2,329,480 shares |
|  | 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br> 2,329,480 shares | Aggregate Amount Beneficially Owned by Each Reporting Person<br> 2,329,480 shares | Aggregate Amount Beneficially Owned by Each Reporting Person<br> 2,329,480 shares | Aggregate Amount Beneficially Owned by Each Reporting Person<br> 2,329,480 shares |
|  | 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) □ | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) □ | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) □ | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) □ |
|  | 11. | Percent of Class Represented by Amount in Row (9)<br> 5.3% (2) | Percent of Class Represented by Amount in Row (9)<br> 5.3% (2) | Percent of Class Represented by Amount in Row (9)<br> 5.3% (2) | Percent of Class Represented by Amount in Row (9)<br> 5.3% (2) |
|  | 12. | Type of Reporting Person (See Instructions)<br> IN | Type of Reporting Person (See Instructions)<br> IN | Type of Reporting Person (See Instructions)<br> IN | Type of Reporting Person (See Instructions)<br> IN |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a "group" for
purposes of this Schedule 13G.

&nbsp;&nbsp;&nbsp;&nbsp;(2) The percent of class was calculated based on 44,164,683 shares of Common Stock outstanding as of November 7, 2022, as reported in
the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 10, 2022.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| CUSIP No. 49705R 10 5 | CUSIP No. 49705R 10 5 | CUSIP No. 49705R 10 5 | CUSIP No. 49705R 10 5 | CUSIP No. 49705R 10 5 | CUSIP No. 49705R 10 5 |
|  | 1. | Names of Reporting Persons<br> Ian Charoub | Names of Reporting Persons<br> Ian Charoub | Names of Reporting Persons<br> Ian Charoub | Names of Reporting Persons<br> Ian Charoub |
|  | 2. | Check the Appropriate Box if a Member of a Group (See Instructions) | Check the Appropriate Box if a Member of a Group (See Instructions) | Check the Appropriate Box if a Member of a Group (See Instructions) | Check the Appropriate Box if a Member of a Group (See Instructions) |
|  |  | (a) | (a) | ¨ | ¨ |
|  |  | (b) | (b) | ⌧ (1) | ⌧ (1) |
|  | 3. | SEC Use Only | SEC Use Only | SEC Use Only | SEC Use Only |
|  | 4. | Citizenship or Place of Organization <br> Palestine | Citizenship or Place of Organization <br> Palestine | Citizenship or Place of Organization <br> Palestine | Citizenship or Place of Organization <br> Palestine |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 5. | 5. | Sole Voting Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 6. | 6. | Shared Voting Power <br> 2,329,480 shares |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 7. | 7. | Sole Dispositive Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 8. | 8. | Shared Dispositive Power <br> 2,329,480 shares |
|  | 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br> 2,329,480 shares | Aggregate Amount Beneficially Owned by Each Reporting Person<br> 2,329,480 shares | Aggregate Amount Beneficially Owned by Each Reporting Person<br> 2,329,480 shares | Aggregate Amount Beneficially Owned by Each Reporting Person<br> 2,329,480 shares |
|  | 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) □ | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) □ | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) □ | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) □ |
|  | 11. | Percent of Class Represented by Amount in Row (9)<br> 5.3% (2) | Percent of Class Represented by Amount in Row (9)<br> 5.3% (2) | Percent of Class Represented by Amount in Row (9)<br> 5.3% (2) | Percent of Class Represented by Amount in Row (9)<br> 5.3% (2) |
|  | 12. | Type of Reporting Person (See Instructions)<br> IN | Type of Reporting Person (See Instructions)<br> IN | Type of Reporting Person (See Instructions)<br> IN | Type of Reporting Person (See Instructions)<br> IN |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a "group" for
purposes of this Schedule 13G.

&nbsp;&nbsp;&nbsp;&nbsp;(2) The percent of class was calculated based on 44,164,683 shares of Common Stock outstanding as of November 7, 2022, as reported in
the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 10, 2022.

---

| | |
|:---|:---|
| Introductory Note: This statement on Schedule 13G is filed on behalf of the Reporting Persons, in respect of shares of Common Stock ("Common Stock") of Kinnate Biopharma Inc. (the "Issuer"). | Introductory Note: This statement on Schedule 13G is filed on behalf of the Reporting Persons, in respect of shares of Common Stock ("Common Stock") of Kinnate Biopharma Inc. (the "Issuer"). |
| **Item 1.** | **Item 1.** |
|  (a) | Name of Issuer:<br>Kinnate Biopharma Inc. |
|  (b) | Address of Issuer's Principal Executive Offices:<br>11975 El Camino Real, Suite 101<br> San Diego, CA 92130 |
| **Item 2.** | **Item 2.** |
|  (a) | Name of Reporting Persons Filing:<br>Nextech V Oncology S.C.S., SICAV-SIF ("Nextech V LP")<br> Nextech V GP S.à r.l. ("Nextech V GP")<br> Thomas Lips ("Lips ")<br> Dalia Bleyer ("Bleyer")<br> Ian Charoub ("Charoub") |
|  (b) | Address of Principal Business Office or, if none, Residence:<br>8 rue Lou Hemmer<br> L-1748 Luxembourg-Findel<br> Grand-Duché de Luxembourg |
|  (c) | Citizenship<br>|

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;<u>Name</u> | &nbsp;&nbsp;<u>Citizenship or Place of Organization</u> |
| &nbsp;&nbsp;Nextech V LP- | &nbsp;&nbsp;Luxembourg |
| &nbsp;&nbsp;Nextech V GP- | &nbsp;&nbsp;Luxembourg |
| &nbsp;&nbsp;Lips | &nbsp;&nbsp;Switzerland |
| &nbsp;&nbsp;Bleyer | &nbsp;&nbsp;Lithuania |
| &nbsp;&nbsp;Charoub | &nbsp;&nbsp;Palestine |

---

---

| | | |
|:---|:---|:---|
|  | (d) | Title of Class of Securities:<br>Common stock, $0.0001 par value |
|  | (e) | CUSIP Number:<br>49705R 10 5 |
| **Item 3.** | **If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:** | **If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:** |
|  | Not applicable | Not applicable |

---

**Item 4.** **Ownership**

The following information with respect to the ownership of Common Stock of the Issuer by the Reporting Persons filing this statement on Schedule 13G is provided as of December 31, 2022.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Reporting Persons** | **Shares of**<br> **Common**<br> **Stock Held**<br> **Directly** | **Sole**<br> **Voting**<br> **Power** | **Shared**<br> **Voting**<br> **Power (1)** | **Sole**<br> **Dispositive**<br> **Power** | **Shared**<br> **Dispositive**<br> **Power (1)** | **Beneficial**<br> **Ownership** | **Percentage**<br> **of Class (1) (2)** |
| Nextech V LP | 2329480 | 2329480 | 0 | 2329480 | 0 | 2329480 | 5.3% |
| Nextech V GP (1) | 0 | 2329480 | 0 | 2329480 | 0 | 2329480 | 5.3% |
| Lips (1) | 0 | 0 | 2329480 | 0 | 2329480 | 2329480 | 5.3% |
| Bleyer (1) | 0 | 0 | 2329480 | 0 | 2329480 | 2329480 | 5.3% |
| Charoub(1) | 0 | 0 | 2329480 | 0 | 2329480 | 2329480 | 5.3% |

---

(1) The shares are held by Nextech V LP. Nextech V GP serves as the sole general partner of Nextech V LP
 and has sole voting and investment control over the shares owned by Nextech V LP and may be deemed to own beneficially the shares
 held by Nextech V LP. Nextech V GP owns no securities of the Issuer directly. Lips, Bleyer and Charoub are members of the board of
 managers of Nextech V GP and share voting and dispositive power over the shares held by Nextech V LP, and may be deemed to own
 beneficially the shares held by Nextech V LP. The managing members own no securities of the Issuer directly.

(2) The
percent of class was calculated based on 44,164,683 shares of Common Stock outstanding as of November 7, 2022, as reported in the Issuer's
Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 10, 2022 .

---

| | |
|:---|:---|
| **Item 5.** | **Ownership of Five Percent or Less of a Class** |
|  | If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ◻. |
| **Item 6.** | **Ownership of More than Five Percent on Behalf of Another Person** |
|  | Not applicable |
| **Item 7.** | **Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person** |
|  | Not applicable |
| **Item 8.** | **Identification and Classification of Members of the Group** |
|  | Not applicable |
| **Item 9.** | **Notice of Dissolution of Group** |
|  | Not applicable |
| **Item 10.** | **Certification** |
|  | Not applicable |

---

**Signature**

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 14, 2023

---

| | |
|:---|:---|
| **Nextech V Oncology S.C.S., SICAV-SIF** | **Nextech V Oncology S.C.S., SICAV-SIF** |
| By: | Nextech V GP S.à r.l. |
| its | General Partner |
| By: | /s/ Dalia Bleyer |
|  | Dalia Bleyer, Managing Member |
| By: | /s/ Thomas Lips |
|  | Thomas Lips, Managing Member |
| **Nextech VI GP S.à r.l.** | **Nextech VI GP S.à r.l.** |
| By: | /s/ Dalia Bleyer |
|  | Dalia Bleyer, Managing Member |
| By: | /s/ Thomas Lips |
|  | Thomas Lips, Managing Member |
| /s/ Dalia Bleyer | /s/ Dalia Bleyer |
| Dalia Bleyer | Dalia Bleyer |
| /s/ Thomas Lips | /s/ Thomas Lips |
| Thomas Lips | Thomas Lips |
| /s/ Ian Charoub | /s/ Ian Charoub |
| Ian Charoub | Ian Charoub |

---